Form 4: USANA Health Sciences: Chief Legal Officer Joshua Foukas Reports Stock Unit Grant

Joshua Foukas, Chief Legal Officer of USANA Health Sciences, reports the acquisition of restricted stock units.

Summary

• On February 27, 2025, Joshua Foukas, the Chief Legal Officer of USANA Health Sciences, was granted 26,306 restricted stock units (RSUs).
• These RSUs represent a contingent right to receive one share of USNA common stock each.
• The RSUs vest at a rate of 25% per year, starting on February 27th of each year.
• Following this transaction, Foukas directly owns 44,887 derivative securities.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation practice, which is generally viewed neutrally to positively as it aligns management with shareholder interests.

Positives

• The grant of restricted stock units aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the Chief Legal Officer.

Industry Context

Stock grants to executives are a common practice in the health and wellness industry to incentivize performance and align management interests with shareholder value.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages across various industries, including companies like Herbalife and Nu Skin.
• The vesting schedule of 25% annually is a fairly standard practice for RSU grants.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive sign, indicating confidence in the company's future performance.
• Employees may see the grant as a sign of stability and investment in leadership.

Key Dates